Navigation Links
BR Ventures Invests in Semprae Laboratories
Date:3/10/2010

Student-run venture fund joins Quaker BioVentures in Series A round

ITHACA, N.Y., March 10 /PRNewswire-USNewswire/ -- BR Ventures (BRV), an MBA student-run venture fund of the Johnson School at Cornell University, today announced that it has invested in Semprae Laboratories, joining Quaker Biosciences, which led the Series A round. Semprae is the maker of Zestra® Essential Arousal Oils™, the only topical, non-prescription product clinically proven to improve desire, arousal and satisfaction in women.

Started by brand experts, CEO Mary Wallace Jaensch and President Rachel Braun Scherl, Semprae is focused on providing women with real solutions for sexual satisfaction. BRV recognized the opportunity to invest in a market-leading, revolutionary product that improves women's lives. The deal represents BRV's first co-investment with Quaker BioVentures, a leading life sciences venture fund headquartered in Philadelphia.

"BR Ventures' investment is yet another endorsement of the great strides we are making to bring Zestra into the homes of women around the world," said Mary Wallace Jaensch, CEO of Semprae Laboratories. "We are igniting the conversation among women and, with the help of our investors, we are expanding our reach and impact."

Semprae Laboratories is a unique investment for BRV, which typically invests in seed stage companies. The deal is the second of the year for the Fund, following an investment in biotechnology company, Adenios, in January.

"We are thrilled to join Quaker BioVentures in this round," said Uma Kakde, Manager of BR Ventures. "This is a one of a kind deal for us. Semprae is addressing an enormous market – over 30 million women in the United States - with a very real need. With proven management and demonstrated execution, we are confident that Zestra will become the standard in this category."

BR Ventures is committed to sourcing and investing in the best deals from within Cornell University and beyond. Co-investing with other venture capital firms—in this case, Quaker BioVentures—is key to BRV's strategy, both from the perspective of the Fund's investment philosophy as well as for the educational mission that the Fund serves.

About BR Ventures

BR Ventures (BRV) is an MBA student-run, evergreen, early stage venture fund of the Johnson Graduate School of Management at Cornell University. With over eight portfolio companies spanning high-tech, healthcare, biotech and sustainable technologies, BRV's investments represent the cutting edge research at Cornell University. BRV is committed to promoting entrepreneurship at Cornell and in the local community. It has several partnerships with prominent angel VC groups in upstate New York and with bigger firms in the Northeastern region of the United States. For more information, visit: www.johnson.cornell.edu/brv.

All trademarks are the property of their respective owners.

SOURCE BR Ventures

Back to top

RELATED LINKS
http://www.johnson.cornell.edu/brv

'/>"/>

SOURCE BR Ventures
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Hank Plain Joins Morgenthaler Ventures as Partner
2. Dan Broderick Joins Prolog Ventures as Partner
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. Khosla Ventures and BIOeCON Form KiOR Inc.
6. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
7. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
8. Clarus Ventures Closes $660 Million Fund
9. The Bill & Melinda Gates Foundation, BIO, and Bio Ventures for Global Health Invite Proteome Systems CEO to Speak on TB Diagnostics Solutions At Partnering for Global Health Forum, Washington D.C.
10. Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
11. SPO Medical Retains American Capital Ventures for Investor Relations Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... ... Drive Precision Farming in 2017 and Beyond. The paper outlines the key trends ... precision ag industry. , “We’ve witnessed a lot of highs and lows as ...
(Date:5/23/2016)... 23, 2016 - Leading CRO,s Use of ... - Frontage Implement a Single Platform to Manage End-to-end Operations Across ... the Bioanalytical lab Frontage Laboratories, a full-service contract research ... and China , has selected IDBS, ... addition to serving as the global electronic lab notebook (ELN), the ...
(Date:5/22/2016)... ... 22, 2016 , ... Doctors in Rome say micronutrients found in certain foods ... Surviving Mesothelioma has just posted an article on the new research. Click here ... Clinical Sciences and Translational Medicine evaluated more than 150 studies on polyphenols in cancer ...
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, ... new way to treat the disease. Surviving Mesothelioma has just posted an article on ... several Korean institutions based their mesothelioma study on the fact the Manumycin A, a ...
Breaking Biology Technology:
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):